Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy. This evidence concerns the gene IL1RL2 and pyoderma gangrenosum.